Effects of exercise in a islet-transplanted half-marathon runner: Outcome on diabetes management, training and metabolic profile

Sport Sciences for Health

Volumn 10, Issue 1, 2014, Pages 49-52

  Delmonte, V ^a,b,c   Codella, R ^a,b,c   Piemonti, L ^d   La Torre, A ^a   Benedini, S ^a,c   Maffi, P ^d   Ricordi, C ^b   Luzi, L ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897047747     PISSN: 18247490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11332-013-0164-7     Document Type: Article

References (9)

1. Skyler JS, Ricordi C (2011) Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man. Diabetes 60: 1-8.
2. Shapiro JAM (2011) State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep 11: 345-354.
3. Bassi R, Fiorina P (2011) Impact of islet transplantation on diabetes complications and quality of life. Curr Diab Rep 11: 355-363.
4. Lopes Souto D, Paes de Miranda M (2011) Physical exercises on glycemic control in type 1 diabetes mellitus. Nutr Hosp 26: 425-429.
5. ADA (2003) ADA position statement: physical activity/exercise and diabetes mellitus. Diabetes Care 26: 73-77.
6. Painter P (2005) Exercise following organ transplantation: a critical part of the routine post transplant care. Ann Transplant 10: 28-30.
7. Surgit O, Ersoz G, Gursel Y, Ersoz S (2001) Effects of exercise training on specific immune parameters in transplant recipients. Transplant Proc 33: 3298.
8. Piemonti L, Maffi P, Monti L, Lampasona V, Perseghin G, Magistretti P et al (2011) Beta cell function during rapamycin monotherapy in long-term type 1 diabetes. Diabetologia 54: 433-439.
9. Froud T, Faradji RN, Pileggi A, Messinger S, Baidal DA, Ponte GM et al (2008) The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation 86: 36-45.